ANGELA DIXON: Open Payments
NPI 1770983652 · ELMIRA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$678 in 33 payments from 11 companies in 2025. Trend: 2023 $644 · 2024 $970 · 2025 $678
Food & beverage: $568Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $181 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| UCB, Inc. | 4 | $89 |
| Janssen Biotech, Inc. | 3 | $75 |
| GENZYME CORPORATION | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Lilly USA, LLC | 1 | $35 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Organon LLC | 2 | $22 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, EBGLYSS, AYVAKIT, RINVOQ, ILUMYA.
Industry payments across NY — which companies pay providers there.
